This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Effectiveness and Costs of Enhanced Cocaine Treatments

This study has been completed.
Information provided by:
University of Pennsylvania Identifier:
First received: September 9, 2005
Last updated: December 14, 2009
Last verified: December 2009
The study will evaluate the effectiveness, economic benefits, and costs of voucher reinforcement for cocaine and alcohol abstinence, additional counseling services, and their combination in a sample of cocaine dependent patients receiving outpatient treatment as usual in a community clinic.

Condition Intervention Phase
Cocaine Dependence Behavioral: Voucher Reinforcement Behavioral: Extra Counseling Services Behavioral: Voucher Reinforcement + Extra Counseling Services Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Factorial Assignment
Masking: None (Open Label)
Primary Purpose: Treatment

Further study details as provided by University of Pennsylvania:

Estimated Study Completion Date: February 2007

Ages Eligible for Study:   18 Years to 65 Years   (Adult)
Sexes Eligible for Study:   All

Inclusion Criteria:

  • Enrollment in an intensive outpatient program (IOP) for no more than 1 month
  • Current DSM-IV diagnosis of cocaine dependence (month prior to IOP treatment)
  • 18-65 years of age
  • Ability to provide names of informants to help locate subject for follow-up

Exclusion Criteria:

  • IV heroin use in last year
  • Acute medical/psychiatric diagnosis that precludes outpatient treatment
  • Inpatient treatment for 6 weeks or more prior to IOP treatment
  • Incarceration for 6 months or more prior to IOP treatment
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00167258

United States, Pennsylvania
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104
Sponsors and Collaborators
University of Pennsylvania
Principal Investigator: James R McKay, PhD University of Pennsylvania
  More Information

Responsible Party: Dr. James McKay, University of Pennsylvania Identifier: NCT00167258     History of Changes
Other Study ID Numbers: 702110
Study First Received: September 9, 2005
Last Updated: December 14, 2009

Additional relevant MeSH terms:
Cocaine-Related Disorders
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders processed this record on August 17, 2017